Back to Ovarian Cancer
NCT00003670
NCT00003670
Who may be able to join
Who might be able to join this trial:
- You are a woman aged 18 or older with ovarian cancer (a specific type called epithelial ovarian cancer) or a related cancer called primary peritoneal cancer, confirmed by laboratory testing of tumor tissue
- Your cancer has spread to other parts of the body and has not responded to previous treatment
- You have previously been treated with chemotherapy that included at least one platinum-based drug and one taxane-based drug — unless your doctor determined these were not suitable for you due to nerve damage, kidney problems, or an allergic reaction (to Taxol only)
- Your cancer can be measured in two directions using X-ray, CT scan, MRI, or physical examination
- Your estrogen receptor status is known, or tumor tissue is available to be tested for it
- You are generally in good health and able to carry out normal daily activities (confirm with trial site)
- You are expected to live for at least 24 weeks
- Your blood counts and organ function meet certain healthy levels — including your white blood cells, platelets, hemoglobin, liver, and kidney values (confirm with trial site)
Who may not be able to join:
- You have had another cancer in the past 5 years, unless it was a minor skin cancer (non-melanoma) or a very early-stage cervical condition that was fully treated
- You have had more than 2 previous chemotherapy regimens if your cancer may still respond to platinum-based treatment
- You have had more than 3 previous chemotherapy regimens if your cancer does not respond to platinum-based treatment
- You have received certain chemotherapy drugs (mitomycin or nitrosoureas) within the last 6 weeks, or any other chemotherapy within the last 3 weeks
- You have not yet fully recovered from side effects of previous chemotherapy
- You have received hormone replacement therapy within the last 3 weeks
- You have previously had hormonal therapy specifically to treat your ovarian cancer
- You have had radiotherapy within the last 2 weeks, or have not yet fully recovered from it
- Fluid build-up in the abdomen (ascites) alone cannot be used to measure your cancer for this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 2
Sponsor
Eli Lilly and Company
Registry
clinicaltrials_gov
Start date
1 October 1998
Where this trial is recruiting
🇺🇸 United States
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.